Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247781 | SCV000312945 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000247781 | SCV000340987 | likely benign | not specified | 2016-04-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000247781 | SCV000594097 | uncertain significance | not specified | 2016-11-07 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659296 | SCV000781101 | uncertain significance | CHARGE association | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311395 | SCV000847071 | likely benign | Inborn genetic diseases | 2017-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institute for Genomic Medicine |
RCV000247781 | SCV000864332 | likely benign | not specified | 2017-07-17 | criteria provided, single submitter | clinical testing | BS1, BP1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, is a missense alteration in a gene for which primarily truncating variants are known to cause disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
Invitae | RCV000659296 | SCV001000714 | likely benign | CHARGE association | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001160695 | SCV001322516 | benign | Hypogonadotropic hypogonadism 5 with or without anosmia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV001528317 | SCV001940185 | benign | not provided | 2019-10-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24862881, 29419413, 23533228, 16763960, 22539353, 28135719, 18834967) |
Ce |
RCV001528317 | SCV004155844 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | CHD7: BS1 |
Diagnostic Laboratory, |
RCV001528317 | SCV001739856 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001528317 | SCV001798732 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528317 | SCV001958548 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528317 | SCV001964768 | likely benign | not provided | no assertion criteria provided | clinical testing |